PPTA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Perpetua Resources Corp. to Contact the Firm Today! — Neutral
PPTA Accesswire — May 16, 2025NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Perpetua Resources Corp. ("Perpetua" or "the Company") (NASDAQ:PPTA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Perpetua securities between April 17, 2024 and February 13, 2025, both dates inclusive (the "Class Period").

SANA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Sana Biotechnology, Inc. to Contact the Firm Today! — Neutral
SANA Accesswire — May 16, 2025NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or "the Company") (NASDAQ:SANA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Sana securities between March 17, 2023 and November 4, 2024, both dates inclusive (the "Class Period").

BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat) — Neutral
BCRX GlobeNewsWire — May 16, 2025RESEARCH TRIANGLE PARK, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO® (berotralstat) in adolescents and people with severe HAE showing significant and sustained reductions in HAE attack rates through 18 months of follow-up after beginning treatment with ORLADEYO in both patient populations.

Tawazun Council, RTX and EGA Sign MOU to Explore Gallium Production in Abu Dhabi — Neutral
RTX PRNewsWire — May 16, 2025ABU DHABI , May 16, 2025 /PRNewswire/ -- Today, Tawazun Council; aerospace and defense company RTX (NYSE: RTX); and Emirates Global Aluminium (EGA), the world's largest producer of "premium aluminium," signed a memorandum of understanding to establish EGA as a new producer of gallium, a critical mineral used across global supply chains. This initiative would create gallium extraction and refining capabilities at EGA's alumina refinery in Abu Dhabi and make the UAE the world's second largest producer of gallium.

THOMASVILLE, Ga. , May 16, 2025 /PRNewswire/ -- Flowers Foods, Inc. (NYSE: FLO) today reported financial results for the company's 16-week first quarter ended April 19, 2025.

RKT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Rock Holdings, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
RKT Accesswire — May 16, 2025NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rock Holdings, Inc. ("RHI" or "the Company") (NYSE:RKT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Rocket Companies, Inc. ("Rocket") Class A common stock between February 25, 2021 and May 5, 2021, both dates inclusive (the "Class Period").

Reports Q1 2025 Results with Net Revenues and Gross Profit Increases of 15.9% Respectively, as Compared to Q1 2024 Conference Call Scheduled for Friday, May 16, at 9:00 a.m. Eastern Time (Friday, May 16, at 9:00 p.m.

BITF SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bitfarms Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
BITF Accesswire — May 16, 2025NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bitfarms Ltd. ("Bitfarms" or "the Company") (NASDAQ:BITF) and certain of its officers.

DMRC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Digimarc Corporation Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
DMRC Accesswire — May 16, 2025NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Digimarc Corporation ("Digimarc" or "the Company") (NASDAQ:DMRC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Digimarc securities between May 3, 2024 and February 26, 2025, both dates inclusive (the "Class Period").

Brady Corporation Reports Record Adjusted EPS in its Fiscal 2025 Third Quarter and Tightens its Fiscal 2025 EPS Guidance — Neutral
BRC GlobeNewsWire — May 16, 2025MILWAUKEE, May 16, 2025 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE: BRC) (“Brady” or “Company”), a world leader in identification solutions, today reported its financial results for its fiscal 2025 third quarter ended April 30, 2025.

UNH SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that UnitedHealth Group Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
UNH Accesswire — May 16, 2025NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE:UNH) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired UnitedHealth securities between September 22, 2021 and April 16, 2025, both dates inclusive (the "Class Period").

WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
WST Accesswire — May 16, 2025NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").

ELV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elevance Health, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
ELV Accesswire — May 16, 2025NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Elevance securities between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period").

CODI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Compass Diversified Holdings Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! — Neutral
CODI Accesswire — May 16, 2025NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Compass Diversified Holdings ("Compass" or "the Company") (NYSE:CODI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Compass securities between May 1, 2024 and May 7, 2025, both dates inclusive (the "Class Period").

TBBK Investors Have Opportunity to Lead The Bancorp, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
TBBK PRNewsWire — May 16, 2025LOS ANGELES , May 16, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Bancorp, Inc. ("Bancorp" or "the Company") (NASDAQ: TBBK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 25, 2024 and March 4, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 16, 2025.

STAAR Surgical Announces $30 Million Share Repurchase Authorization — Neutral
STAA Business Wire — May 16, 2025LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $30 million of its outstanding common stock. “Our decision to initiate a share repurchase program underscores the Board's and management's confidence in STAAR's future and.

Neurogene Announces Evidence-Based Monitoring and Treatment Intended to Reverse Rare Hyperinflammatory Syndrome Associated with High-Dose AAV — Neutral
NGNE Business Wire — May 16, 2025NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced an oral presentation at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting describing a monitoring and treatment algorithm intended to reverse the rare, severe hyperinflammatory syndrome hemophagocytic lymphohistiocytosis (HLH) that has been associated with systemic e.

UCTT Investors Have Opportunity to Lead Ultra Clean Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
UCTT PRNewsWire — May 16, 2025LOS ANGELES , May 16, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ultra Clean Holdings, Inc. ("Ultra Clean" or "the Company") (NASDAQ: UCTT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 6, 2024 and February 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 23, 2025.

VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
VTRS PRNewsWire — May 16, 2025LOS ANGELES , May 16, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Viatris Inc. ("Viatris" or "the Company") (NASDAQ: VTRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 8, 2024 and February 26, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 3, 2025.

NPWR Investors Have Opportunity to Lead NET Power Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
NPWR PRNewsWire — May 16, 2025LOS ANGELES , May 16, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against NET Power Inc. ("Net Power" or "the Company") (NYSE: NPWR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 9, 2023 and March 7, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 17, 2025.
